Landscapes / Companies
InventisBio Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
2 in Phase 2
Drugs
5
in active trials · 7 in all
Trials
15 active
31 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Nov 2026soonPhase 3 trial completes | |||
| Next date | 30 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | 12 Jul 2027Phase 3 trial completes | |||
| Next date | 12 Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Plaque Psoriasis, UC - Ulcerative Colitis and 9 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
InxMed (Shanghai) |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | ||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2028Phase 1 trial completes | |||
| Next date | 30 Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor Cancer | ||||
| Open drug page | |||||
About
- No active trial
- Befotertinib, D-0120
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021